Table 1.

Patient characteristics before and after telbivudine treatment

	CD3/macrophages (cells/mm2)	DNA (copy number)	mRNA (copy number)	Ejection fraction (%)	New York Heart Association
Before
Patient 1	9/31	2642	1583	57	II
Patient 2	9/34	16	90	35	II
Patient 3	21/9	15	53	30	III
Patient 4	28/178	145	371	50	III
After
Patient 1	0/16	196	ND	64	I‐II
Patient 2	0/8	72	ND	45	I‐II
Patient 3	7/11	189	ND	42	II
Patient 4	6/31	418	ND	61	II

ND, not detectable.